Archive for the ‘Health News’ Category

Dr Noel’s Only Wish Is To See His Baby Daughter

Sunday, October 27th, 2013

Jared and Hannah Noel NZ Herald Jared Noel has just one wish before he dies following a five-year battle with cancer: to see his yet-to-be-born daughter.

“My greatest hope is that I get to spend some time with her and enjoy fatherhood. She won’t know me. She won’t remember me. But I’d like to let her know how much I would have wanted to be there when she’s 18, when she’s 25,” he said.

Dr Noel, 32, a physician at Auckland City Hospital, New Zealand was diagnosed with bowel cancer in November 2008. He has since battled through 66 rounds of chemotherapy and two major operations. Despite knowing the cancer would eventually beat him, he and his wife, Hannah, decided to try for a baby in the hope that he would live long enough to experience the first part of his child’s life. After four rounds of IVF, they succeeded, and their daughter is due on January 21. But last week, the couple were given the devastating news that the cancer had grown rampantly in Dr Noel’s liver and spread to his lung.

Without more chemo, it was unlikely he would live past Christmas. “This is the moment we have been dreading for five years and have been lucky to escape until now,” Dr Noel wrote on his blog on Saturday after receiving the diagnosis. “This is where everything changes. I have a lifespan measured in months. “The disappointment is compounded by knowing we have a daughter waiting to meet us, and for the first time, doubt has been cast over whether or not I will make that meeting. This is aggressive cancer, doing its best to kill me, to rob our child of their father.”

The couple did not have the money to pay for the drug Avastin, which it’s hoped will slow the growth of the tumours enough to extend Dr Noel’s life expectancy beyond the birth of his daughter – though it will not cure him. Ten courses of the medicine, which is not funded by Pharmac, cost $60,000.

Dr Noel said he had always been “a little reluctant to pay for a drug that does not change outcome”. But in light of his imminent fatherhood, he said, his life expectancy had become more important and he was open to fundraising for the Avastin.

“If it wasn’t for her [the baby], we would do our best and let nature take its course. But all of a sudden months and weeks are the difference between meeting my daughter or not and maybe the difference between me having a few months with her or not. It means a lot to Hannah, as she’ll get to see me holding her. I’m doing it mainly for Hannah and my daughter now.”

As a result they allowed a friend to set up a page on fundraising site Givealittle appealing for the $60,000. The page went live last week and within seven hours it had raised the money. Within days the fund has reached $158,000. Many of the donations came from anonymous donors or people who did not know the Noels.

One woman has offered to give Dr. Noel her own Avastin injections, which she receives every two months.  The 67-year-old, who lives in Glen Eden, Auckland is starting to lose her eyesight and while the injections are not a cure, they are helping to slow the process. “It’s fully funded and I have no idea why this young man can’t get Avastin injections for his much worse problem. But I am absolutely prepared to give up my Avastin injections. I’m losing my sight. But I don’t care about that. This boy needs to be given some time. It’s just sensible. I’m 67 years old, why do I need them?  This is a young boy with a family coming.

A Givealittle spokeswoman said it was the quickest a fundraising target had been reached since the site was set up in December 2008.

Dr Noel said he was overwhelmed by the generosity shown. “I have no words. We’re just stunned. We’re grateful and humbled by it all. It’s just so overwhelming. I knew there was some support and empathy out there but the response that we’ve got – I have no words.” He said the extra money raised would go towards giving his wife financial security after he is gone. However, if it continued to come in at the present rate, he would consider setting up a trust to benefit his daughter.

Dr Noel said he planned to have his first course of Avastin and restart chemotherapy next week. He vowed to give his all to make sure he was there for the birth of his daughter.

“I’m at the business end of the fight now. But I’ve outlived everybody’s expectations so far. I can make it.”

Source: NZ Herald.

New Hearts To Be Grown From Stem Cells

Wednesday, October 2nd, 2013

By Ronda Wendler, Texas Medical Center News 

Building natural organs from stem cells is the way forward in regenerative medicine.

Building natural organs from stem cells is the way forward in regenerative medicine.

The Texas Heart Institute and the veterinary medicine college at Texas A&M University will share a $3 million award from the state of Texas’ Emerging Technology Fund to create the Center for Cell and Organ Biotechnology.

“This center will play a key role in securing Texas’ very critical emerging role in biotechnology,” Gov. Rick Perry said at a Press Conference at the Heart Institute. “The sky is truly the limit for what this center will be able to accomplish.”

The new collaboration will focus on cell therapies and regenerative medicine, including building natural organs from stem cells.

Doris Taylor, Ph.D., who in 2008 created a beating rat heart at the University of Minnesota, was recruited to the Texas Heart Institute last year and will head the new center.

“Dr. Taylor is certainly one of the stars in the adult human stem cell field, and we feel extremely fortunate to have her,” said James Willerson, M.D., the Texas Heart Institute’s president and medical director.

Taylor is the developer of a technique known as decellularization, which involves stripping cells from an animal heart, leaving only a shell or scaffold of the heart in place, then infusing the scaffold with human stem cells to grow a new human heart.

At the Heart Institute, Taylor has created human heart models that are currently functioning at one-fourth capacity. She hopes to engineer a heart that functions at close to 100 percent capacity by 2015. The goal is to test such bioengineered hearts in clinical trials, probably in less than 10 years, she said, and eventually offer a solution to patients waiting for donor hearts, which are always in short supply.

Other scientists around the world are striving to do the same, and Texas Heart Institute founder Denton Cooley, M.D., said during the press conference that successful culmination of the institute’s efforts to engineer a human heart would be a fitting continuation of the heart institute’s legacy.

The decellularization approach is also being tried with other organs, Taylor said, including livers, kidneys and lungs.

Texas A&M’s College of Veterinary Medicine and Biomedical Sciences will contribute animal disease models to be used in cell therapy trials, as well as bioengineers who will build scaffolding upon which heart cells will grow. and experts in anatomy, physiology and stem cell science.

Scientists from the Heart Institute and Veterinary College will collaborate not only to grow new organs, but also to detect diseases earlier and to devise new cell and gene therapies to help prevent and treat diseases and injuries.

Texas A&M has more than 20,000 veterinary cases a year of animals with disease, and therefore will be invaluable in providing animals that can contribute to and benefit from this research, Taylor said.

Veterinarians and Heart Institute scientists will collaborate in other ways as well, she said. For example, racehorses with tendonitis are already being treated with stem cell therapy, and lessons learned could help human athletes. Doberman Pinschers routinely get heart disease and could benefit from the regenerative medicine efforts underway at the heart institute.

“It was clear from the beginning that this partnership was special,” said Eleanor Green, D.V.M., dean of A&M’s College of Veterinary Medicine and Biomedical Sciences. “We know that the health of animals and people is inextricably linked, and this unique center will advance both human and animal health.”

The state of Texas’ Emerging Technology Fund that funds the new center is a technology investment fund created at the urging of Gov. Rick Perry to give Texas an advantage in developing and commercializing emerging technologies. Launched in 2005, the fund has given out more than $200 million to startup companies and educational institutions.

The Texas Heart Institute’s next step, Taylor said, is to hire a technology transfer expert who will help form spin-off companies and commercialize its inventions.